Terns Pharmaceuticals, Inc.
TERNDelisted May 5, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831363
Terns Pharmaceuticals, Inc. was delisted on May 5, 2026; its insiders filed their last Form 4 on May 5, 2026; 317 institutions reported holding it in 13F filings for Q1 2026, worth $6.56B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q3 2021
Institutional positions in Terns Pharmaceuticals, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- −2 vs. Q2 2021
- Shares held
- 16.7M
- +103.8K (+0.6%) vs. Q2 2021
- Total value
- $174.3M
- −$29.5M (−14.5%) vs. Q2 2021
- New holders
- 3
- 17 more added
- Sold out
- 5
- 7 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TERN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $75.4K |
| Q1 2026 | 317 | $6.56B |
| Q4 2025 | 248 | $4.95B |
| Q3 2025 | 141 | $665.7M |
| Q2 2025 | 130 | $310.0M |
| Q1 2025 | 138 | $229.4M |
| Q4 2024 | 157 | $477.2M |
| Q3 2024 | 156 | $663.1M |
| Q2 2024 | 126 | $446.7M |
| Q1 2024 | 112 | $414.8M |
| Q4 2023 | 103 | $412.7M |
| Q3 2023 | 93 | $310.4M |
| Q2 2023 | 103 | $505.0M |
| Q1 2023 | 79 | $630.2M |
| Q4 2022 | 65 | $506.2M |
| Q3 2022 | 45 | $178.1M |
| Q2 2022 | 42 | $36.5M |
| Q1 2022 | 44 | $50.0M |
| Q4 2021 | 37 | $116.7M |
| Q3 2021 | 34 | $174.3M |
| Q2 2021 | 36 | $203.8M |
| Q1 2021 | 42 | $393.7M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Terns Pharmaceuticals, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 3,791,204 | $39.5M | 0.44% | 00.0% | Unchanged |
| FMR LLC | 2,933,162 | $30.6M | 0.00% | −89,395−3.0% | Reduced |
| Vivo Capital, LLC | 2,675,133 | $27.9M | 1.25% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 2,345,959 | $24.4M | 0.48% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 1,125,736 | $11.7M | 0.20% | +600+0.1% | Added |
| Matthews International Capital Management LLC | 875,068 | $9.12M | 0.55% | −196,353−18.3% | Reduced |
| Antara Capital LP | 774,834 | $8.07M | 1.59% | −1,100−0.1% | Reduced |
| BlackRock Inc. | 602,556 | $6.28M | 0.00% | +164,952+37.7% | Added |
| Vanguard Group Inc | 440,672 | $4.59M | 0.00% | +24,942+6.0% | Added |
| Samsara BioCapital, LLC | 289,068 | $3.01M | 0.50% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 193,336 | $2.01M | 0.00% | +50,267+35.1% | Added |
| State Street Corp | 150,340 | $1.57M | 0.00% | +21,637+16.8% | Added |
| Northern Trust Corp | 116,916 | $1.22M | 0.00% | +30,133+34.7% | Added |
| Jacobs Levy Equity Management, Inc | 87,534 | $912.0K | 0.01% | +69,884+395.9% | Added |
| Caas Capital Management LP | 85,851 | $895.0K | 0.07% | +65,404+319.9% | Added |
| Cowen and Company, LLC | 85,000 | $886.0K | 0.04% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 31,543 | $329.0K | 0.00% | +10,184+47.7% | Added |
| Bank of New York Mellon Corp | 27,513 | $287.0K | 0.00% | +4,227+18.2% | Added |
| Morgan Stanley | 26,044 | $271.0K | 0.00% | −787−2.9% | Reduced |
| Nuveen Asset Management, LLC | 14,237 | $150.0K | 0.00% | 00.0% | Unchanged |
| S&T Bank | 10,000 | $104.0K | 0.02% | +10,000 | New |
| Deutsche Bank AG | 8,471 | $88.0K | 0.00% | +2,577+43.7% | Added |
| American International Group, Inc. | 7,507 | $78.0K | 0.00% | +2,624+53.7% | Added |
| New York State Common Retirement Fund | 5,874 | $61.0K | 0.00% | +5+0.1% | Added |
| JPMorgan Chase & Co | 5,254 | $55.0K | 0.00% | −6,165−54.0% | Reduced |
| Bank of America Corp | 5,132 | $53.0K | 0.00% | +157+3.2% | Added |
| California State Teachers Retirement System | 4,639 | $48.0K | 0.00% | −7,399−61.5% | Reduced |
| Royal Bank of Canada | 1,751 | $18.0K | 0.00% | +1,155+193.8% | Added |
| Citigroup Inc | 1,592 | $17.0K | 0.00% | +1,177+283.6% | Added |
| Legal & General Group Plc | 1,279 | $13.0K | 0.00% | +400+45.5% | Added |
| Tower Research Capital LLC (TRC) | 759 | $8.00K | 0.00% | −421−35.7% | Reduced |
| Ameritas Investment Partners, Inc. | 708 | $7.00K | 0.00% | 00.0% | Unchanged |
| Public Employees Retirement System of Ohio | 400 | $4.00K | 0.00% | +400 | New |
| Wells Fargo & Company | 15 | $0 | 0.00% | +15 | New |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −18,200−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −14,769−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −11,973−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −10,308−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −60−100.0% | Sold out |